Department of Viroscience, Erasmus Medical Centre, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Department of Viroscience, Erasmus Medical Centre, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands; Viroclinics Biosciences B.V., Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam, The Netherlands.
Vaccine. 2015 Dec 8;33(49):6977-82. doi: 10.1016/j.vaccine.2015.08.038. Epub 2015 Aug 25.
Heterosubtypic immunity is defined as immune-mediated (partial) protection against an influenza virus induced by an influenza virus of another subtype to which the host has not previously been exposed. This cross-protective effect has not yet been demonstrated to the newly emerging avian influenza A viruses of the H7N9 subtype. Here, we assessed the induction of protective immunity to these viruses by infection with A(H1N1)pdm09 virus in a newly developed guinea pig model. To this end, ten female 12-16 week old strain 2 guinea pigs were inoculated intratracheally with either A(H1N1)pdm09 influenza virus or PBS (unprimed controls) followed 4 weeks later with an A/H7N9 influenza virus challenge. Nasal swabs were taken daily and animals from both groups were sacrificed on days 2 and 7 post inoculation (p.i.) with A/H7N9 virus and full necropsies were performed. Nasal virus excretion persisted until day 7 in unprimed control animals, whereas only two out of seven H1N1pdm09-primed animals excreted virus via the nose. Infectious virus was recovered from nasal turbinates, trachea and lung of all animals at day 2 p.i., but titers were lower for H1N1pdm09-primed animals, especially in the nasal turbinates. By day 7 p.i., relatively high virus titers were found in the nasal turbinates of all unprimed control animals but infectious virus was isolated from the nose of only one of four H1N1pdm09-primed animals. Animals of both groups developed inflammation of variable severity in the entire respiratory tract. Viral antigen positive cells were demonstrated in the nasal epithelium of both groups at day 2. The bronchi(oli) and alveoli of unprimed animals showed a moderate to strong positive signal at day 2, whereas H1N1pdm09-primed animals showed only minimal positivity. By day 7, only viral antigen positive cells were found after H7N9 virus infection in the nasal turbinates and the lungs of unprimed controls. Thus infection with H1N1pdm09 virus induced partially protective heterosubtypic immunity to H7N9 virus in (isogenic) guinea pigs that could not be attributed to cross-reactive virus neutralizing antibodies.
异源型免疫是指宿主先前未接触过的另一种亚型流感病毒诱导的针对流感病毒的免疫介导(部分)保护。这种交叉保护作用尚未在新出现的 H7N9 亚型禽流感病毒中得到证实。在这里,我们在新开发的豚鼠模型中评估了感染 A(H1N1)pdm09 病毒对这些病毒的诱导保护性免疫的情况。为此,将 10 只 12-16 周龄的 2 号豚鼠品系雌性豚鼠经气管内接种 A(H1N1)pdm09 流感病毒或 PBS(未接种对照),4 周后用 A/H7N9 流感病毒进行攻毒。每天采集鼻拭子,两组动物均于接种 A/H7N9 病毒后第 2 和 7 天处死,并进行全面尸检。未接种对照动物的鼻病毒排出持续至第 7 天,而 7 只 H1N1pdm09 接种组中只有 2 只通过鼻子排出病毒。在接种后第 2 天,所有动物的鼻腔鼻甲、气管和肺中均能分离到传染性病毒,但 H1N1pdm09 接种组的病毒滴度较低,特别是鼻腔鼻甲。到第 7 天,所有未接种对照动物的鼻腔鼻甲中均检测到相对较高的病毒滴度,但在 4 只 H1N1pdm09 接种组中只有 1 只通过鼻子分离到传染性病毒。两组动物的整个呼吸道均出现不同严重程度的炎症。在接种后第 2 天,两组动物的鼻上皮均可见病毒抗原阳性细胞。未接种对照动物的支气管(细支气管)和肺泡在第 2 天呈中度至强阳性信号,而 H1N1pdm09 接种组仅呈轻度阳性。到第 7 天,仅在未接种对照动物的鼻腔鼻甲和肺中感染 H7N9 病毒后才检测到病毒抗原阳性细胞。因此,H1N1pdm09 病毒感染可诱导(同基因)豚鼠对 H7N9 病毒产生部分保护的异源型免疫,但不能归因于交叉反应性病毒中和抗体。